Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone versus placebo for uterine fibroids
ChiCTR-IIR-15007522Phase 3Completed
- Sponsor
- Peking University First Hospital
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mifepristone in Fibromyoma (LM) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Change in volume of the largest uterine fibroid. Started Oct 2009; status: completed.
02
Drugs
mifepristone
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR-IIR-15007522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-15007522.